Interpreting a sodium or potassium result starts with the distribution of body water and these two ions. Body water makes up roughly 40 to 75% of body weight, highest in newborns and lower with age, obesity, and female sex because adipose tissue holds little water. About two-thirds of total body water is inside cells. The remaining third is extracellular and divides into intravascular plasma, interstitial fluid, and small transcellular pools such as cerebrospinal fluid. Plasma water is about 93% of plasma volume, and sodium dissolved in that water is the main osmotic solute of the extracellular compartment. The sodium-potassium ATPase pumps three sodium ions out for every two potassium ions in, maintaining the transmembrane gradients that set cell volume and membrane potential. Total exchangeable sodium and potassium together with total body water determine both extracellular volume and serum sodium, so serum sodium chiefly tracks water balance and effective tonicity, the property that controls cell hydration.1
Osmolality and its measurement
Osmolality is the concentration of dissolved particles per kilogram of solvent, expressed in mOsm/kg. It is a colligative property: in dilute solutions the particle count determines it regardless of particle identity. Dissociation and nonideal interactions keep a simple molar sum from predicting it exactly. Freezing-point or vapor-pressure osmometry measures it. The Quantitative Instrument Measurement Principles lesson explains the instrument physics, and the Specific Gravity and Osmolality lesson describes urine measurement. Volatile solutes are the main practical difference between the two osmometers: volatile alcohols escape into the vapor headspace and produce a falsely low result with vapor-pressure methods, so suspected toxic-alcohol exposure requires freezing-point osmometry together with direct alcohol assays. Osmolarity counts particles per liter of solution and differs from osmolality at body temperature. Report osmolality in mOsm/kg.1
Tonicity, or effective osmolality, counts only solutes that remain outside cell membranes, because only those generate an osmotic gradient that moves water. Glucose is an effective osmole. Urea and ethanol cross membranes readily, so they raise measured osmolality and contribute little effective osmolality. The body maintains plasma osmolality between about 275 and 295 mOsm/kg, and sodium with its anions supplies roughly 90% of it.
Thirst, vasopressin, and volume regulation
A rise of 1 to 2% in osmolality above each system's individual threshold stimulates both thirst and arginine vasopressin (AVP), also called antidiuretic hormone (ADH). Thirst drives water intake. AVP, released from the posterior pituitary, increases collecting-duct water reabsorption. AVP secretion rises steeply with osmolality above the threshold, and its short circulating half-life of roughly 5 to 15 minutes permits minute-to-minute titration. Nonosmotic stimuli can override osmotic control. Reduced arterial filling releases AVP even when osmolality is low, which is why volume-depleted patients concentrate urine despite hypo-osmolality. With AVP fully suppressed and solute intake adequate, the kidney can excrete close to 20 L of dilute urine daily. Persistent hypo-osmolality therefore means either that renal water excretion is impaired, that AVP persists, or that intake has exceeded even maximal diluting capacity, as in primary polydipsia.1
The renin-angiotensin-aldosterone system (RAAS) regulates effective arterial volume separately from tonicity. Falling renal perfusion, low distal sodium delivery, and sympathetic drive release renin from juxtaglomerular cells. Renin generates angiotensin I from angiotensinogen, converting enzyme makes angiotensin II, and angiotensin II constricts arterioles, drives aldosterone release, and stimulates thirst and AVP. Aldosterone promotes distal sodium reabsorption with water following. Atrial wall stretch releases atrial natriuretic peptide (ANP), which promotes sodium excretion and opposes the RAAS.
Calculated osmolality and the osmolal gap
The osmolal gap is the amount by which measured osmolality exceeds the value calculated from the chemistry panel. The standard formula counts only sodium salts, glucose, and urea, so the difference between measured and calculated osmolality indicates unmeasured osmoles:1
Formula variants exist, including a 1.86 sodium coefficient, a potassium term, and an ethanol term, so each laboratory's formula defines its own gap interval, often about −10 to +10 mOsm/kg. An increased gap indicates a neutral unmeasured solute: ethanol, methanol, ethylene glycol, isopropanol, acetone, or mannitol. The gap does not indicate tonicity, because ethanol raises measured osmolality without adding much effective osmolality. A normal gap also does not exclude toxic-alcohol ingestion once the parent alcohol has been metabolized. The toxicology lesson explains that application.
Calculated osmolality = 2 × [Na+] + [glucose]/18 + [BUN]/2.8 = 2 × 137 + 126/18 + 14/2.8 = 274 + 7 + 5 = 286 mOsm/kg
Osmolal gap = 326 − 286 = 40 mOsm/kg
First verify the measured result and the calculation. A gap of this size is consistent with serious poisoning by an unmeasured alcohol or another neutral osmole, so report both the measured and the calculated values according to your laboratory's protocol.
Scroll sideways to see all columns
| Specimen | Reference interval |
|---|---|
| Serum osmolality | 275–295 mOsm/kg |
| Osmolal gap | Method- and formula-specific; often about −10 to +10 mOsm/kg |
Urine osmolality has no single reference interval, because hydration dominates it: random values span roughly 50 to 1,400 mOsm/kg. Interpretation of sodium disorders pairs urine osmolality with serum osmolality, as the hyponatremia and hypernatremia sections show. The cross-discipline reference interval comparison covers method dependence in more detail.
Sodium
When a sodium result falls outside the reference interval, look first at water balance. Sodium is the principal extracellular cation and, with its anions, the main determinant of extracellular tonicity. Serum sodium follows water balance more closely than sodium balance: thirst regulates water intake, AVP regulates water excretion, and aldosterone, angiotensin II, and ANP regulate sodium excretion. The proximal tubule reabsorbs about 60 to 70% of filtered sodium.
Hyponatremia
Hyponatremia is a serum sodium below the laboratory's lower limit, commonly 135 mmol/L. Symptoms, rate of fall, and duration determine how urgent it is, together with the concentration. An acute decline can be dangerous well above 120 mmol/L, and values below 125 mmol/L count as profound. Measured serum osmolality sorts the differential into three classes:1
Scroll sideways to see all columns
| Measured serum osmolality | Class | Laboratory pattern |
|---|---|---|
| Normal, about 275 to 295 mOsm/kg | Pseudohyponatremia, an indirect ion-selective electrode (ISE) measurement artifact with no true sodium depletion | Sodium low by indirect (diluted) ISE, normal by direct (undiluted) ISE, with normal measured osmolality |
| Above about 295 mOsm/kg | Hypertonic (translocational): glucose or mannitol pulls water out of cells and dilutes sodium | Sodium rises with the glucose correction formula; mannitol does not appear in the standard formula |
| Below about 275 mOsm/kg | True hypotonic hyponatremia | Subdivided by urine osmolality and urine sodium below |
Corrected sodium for hyperglycemia. In hypertonic hyperglycemia the correction shows how much of the low sodium is dilution:
Corrected Na+ = measured Na+ + 1.6 × [(glucose mg/dL − 100) ÷ 100]
The 1.6 factor is the traditional estimate. Experimental data average closer to 2.4 mmol/L per 100 mg/dL above 100, and higher still in marked hyperglycemia, so use the factor your laboratory's medical protocol specifies.2
Corrected Na+ (factor 1.6) = 130 + 1.6 × (330 ÷ 100) = 130 + 5.3 = 135.3 mmol/L
Corrected Na+ (factor 2.4) = 130 + 2.4 × (330 ÷ 100) = 130 + 7.9 = 137.9 mmol/L
With either factor, most of the apparent hyponatremia reflects the glucose water shift. Interpret measured osmolality with the solutes present, and use the corrected sodium as a comparison for interpretation. It is not a treatment target.
For true hypotonic hyponatremia, urine osmolality shows whether the kidneys are diluting urine maximally or retaining water under AVP stimulation. Volume status and the accompanying results help determine whether that AVP response is appropriate:
Scroll sideways to see all columns
| Mechanism | Typical causes | Spot urine sodium | Urine osmolality |
|---|---|---|---|
| Extrarenal sodium loss | Vomiting, diarrhea, burns | Often below 20 mmol/L | Concentrated |
| Renal sodium loss | Diuretics, adrenal insufficiency, salt-losing nephropathy, ketonuria | Often 20 to 30 mmol/L or higher | Variable, usually above 100 |
| Low effective arterial volume | Heart failure, cirrhosis, nephrotic syndrome | Below 20 to 30 mmol/L unless diuretics interfere | Above 100 |
| Inappropriate AVP activity | Syndrome of inappropriate antidiuresis (SIAD, formerly SIADH) | Often above 30 mmol/L | Above 100, indicating incomplete dilution, after adrenal, thyroid, and renal causes and diuretics are excluded |
| Intake exceeds diluting capacity | Primary polydipsia, low-solute intake | Variable | Near 100 or lower, maximally dilute |
Diuretic use, chronic kidney disease, and collection timing confound spot urine sodium, so use these thresholds as a guide and interpret them with volume status. Potassium depletion is another mechanism. Sodium with accompanying water partly replaces the potassium lost from cells, which lowers serum sodium and explains the hyponatremia that accompanies marked hypokalemia.1
Pseudohyponatremia is purely analytic. Sodium dissolves in the water fraction of plasma, about 93% of its volume. Gross hyperproteinemia or hyperlipidemia expands the nonaqueous fraction, so an indirect ISE, which dilutes the specimen before measurement, reports the sodium of the diluted total volume and reads low. Measured serum osmolality stays normal because the solute-to-water ratio of the aqueous phase is unchanged. That combination, a low sodium by indirect ISE with a normal measured osmolality, is the bench finding that suggests pseudohyponatremia. Confirm it with a direct, undiluted ISE measurement, as on blood gas analyzers. In vitro hemolysis causes a separate, true dilutional lowering by releasing low-sodium erythrocyte contents into the aqueous phase. It is usually small at ordinary hemolysis levels, and the method's hemolysis policy applies.1
Symptoms depend on both severity and rate of decline. Acute hypotonic hyponatremia can cause severe neurologic symptoms at concentrations tolerated in chronic disease. The treating service decides the rate of sodium correction under institutional protocol. The laboratory contributes serial sodium and osmolality results and critical-value notification.
Hypernatremia
Hypernatremia reflects a water deficit relative to sodium. Intact thirst prevents it, so it is less common than hyponatremia, and its presence means thirst, access to water, or renal concentrating ability has failed, as in infants, patients with impaired mental status, and older adults with blunted osmotic thirst. Urine osmolality with urine volume sorts the mechanisms. A urine osmolality below about 300 mOsm/kg with polyuria fits the pattern of diabetes insipidus, central or nephrogenic. A value of 300 to 800 mOsm/kg fits partial deficiency or an osmotic diuresis. Above about 800 mOsm/kg the kidney is concentrating appropriately, which fits extrarenal water loss, hypodipsia, or a sodium load. Symptoms are neurologic, including altered mental status, seizures, and hyperreflexia. Reported mortality rises steeply above about 160 mmol/L, an association that varies with the population.1
Determination. Serum, lithium-heparin or ammonium-heparin plasma, and whole blood for direct-ISE analyzers are routine. Spot urine supports the hyponatremia patterns and timed urine gives daily excretion. Reject citrate, EDTA, and oxalate tubes, because the citrate additive is itself a sodium salt and the EDTA salts add potassium or sodium. The method is potentiometric ISE measurement: the membrane develops a potential that follows the logarithm of the ion-activity ratio across it, and calibration converts that potential to concentration through the Nernst relationship. Sodium-selective membranes are glass ion-exchange types, and scheduled cleaning limits protein-fouling drift.
Scroll sideways to see all columns
| Specimen | Reference interval |
|---|---|
| Serum, plasma | 135–145 mmol/L |
| Urine sodium, 24 h | Diet-dependent; representative adult interval about 40 to 220 mmol/d |
| CSF | About 135–150 mmol/L |
Under the Clinical Laboratory Improvement Amendments (CLIA), a laboratory using an unmodified FDA-cleared test system verifies that the manufacturer's interval fits its population, and a laboratory using a modified or laboratory-developed method establishes the interval, under 42 CFR 493.1253. Report patient results against your laboratory's own verified interval.3 Certification-examination answers use the ASCP BOC composite chemistry set, which lists sodium at 136 to 145 mmol/L, and the examination reference ranges lesson lists the complete set.4
Potassium
Specimen choice and handling strongly affect a potassium result because of how potassium is distributed. Potassium is the dominant intracellular cation: roughly 140 mmol/L inside cells against 3.5 to 5.1 mmol/L outside, an about 30-fold gradient, with only about 2% of body potassium extracellular. The laboratory measures only that small extracellular pool. The transmembrane gradient sets the resting membrane potential, so either direction of change alters excitability, conduction, and repolarization, and electrocardiographic change correlates loosely with the measured concentration. Potassium also exchanges with hydrogen ion across cell membranes: mineral (non-anion-gap) acidemia shifts potassium out of cells more than organic acidosis does, alkalosis shifts it inward, and insulin status, renal function, and total-body potassium stores modify every response, so no single potassium change per 0.1-unit pH is reliable.5
Regulation. The proximal tubule reabsorbs about 65% of filtered potassium and the thick ascending limb most of the remainder. Distal secretion sets final urinary excretion. Aldosterone increases distal sodium reabsorption through epithelial sodium channels. The resulting lumen-negative potential favors potassium secretion through apical potassium channels. Acid-base status also affects potassium handling. Hydrogen-ion secretion is a separate transport process.7 Insulin and beta-2 adrenergic stimulation buffer acute potassium loads by moving potassium into cells. Severe hypoxia or ischemia and acute digoxin toxicity impair that buffering, and beta-blockers blunt the beta-2 component. Hypomagnesemia increases renal potassium secretion, so the kidney wastes potassium, and hypokalemia typically resolves only after magnesium is repleted.5
Transcellular shifts change plasma potassium without changing total body potassium: exercise, from about +0.3 mmol/L with ordinary exertion to +1 mmol/L or more after exhaustive effort; hyperosmolality, which draws potassium out with water; and mineral acidemia. Cell breakdown releases intracellular potassium: tumor lysis, rhabdomyolysis, trauma, and massive transfusion of stored blood. These shifts are real changes in the patient. In the preanalytic artifacts below, the patient's plasma potassium was never abnormal.
Hypokalemia and hyperkalemia
Hypokalemia. Gastrointestinal losses include vomiting, diarrhea, gastric suction, laxative overuse, and the rare potassium-rich secretory villous adenoma. Renal losses include diuretics, renal tubular acidosis type 1 or 2, hyperaldosteronism, Cushing's syndrome, hypomagnesemia, and lysozymuric leukemia that injures proximal tubules. Shifts into cells include alkalosis, insulin or beta-adrenergic excess, and refeeding after starvation. Poor intake and dilution are additional causes.
Hyperkalemia. Causes of decreased excretion include advanced renal impairment, especially at glomerular filtration rates below about 20 mL/min, adrenal insufficiency and other hypoaldosteronism, type 4 renal tubular acidosis, and potassium-sparing diuretics. Shifts out of cells include mineral acidosis and insulin-deficient hyperosmolar states: in diabetic ketoacidosis the serum value runs high while total-body potassium is depleted, and insulin therapy reveals the deficit. Cellular release occurs in tumor lysis, rhabdomyolysis, trauma, and transfused stored blood. Increased intake includes oral or intravenous replacement.
Hypokalemia above about 3.0 mmol/L usually causes no symptoms. Weakness, cramping, and constipation become more likely lower still, and values below 2.5 mmol/L can progress to flaccid paralysis and respiratory muscle weakness. The arrhythmia risk is greatest for patients with cardiac disease or digoxin therapy. Hyperkalemia is often silent as well, and its weakness and tingling are unreliable warning signs because electrocardiographic change correlates loosely with concentration. Severe arrhythmia can develop without an obvious ECG warning. Common adult critical limits are near 6.0 to 6.5 mmol/L on the high side and about 2.5 mmol/L on the low side, and each laboratory sets its own list. A result at or beyond the limit requires immediate notification of the ordering clinician under 42 CFR 493.1291(g). Document the result, the time, and the recipient.3
Preanalytic artifact in potassium results
When a patient has an unexplained high potassium, investigate the specimen first, because preanalytic artifact is the most common source of spuriously high potassium. Clotting releases potassium from platelets, so serum typically reads 0.1 to 0.7 mmol/L above plasma on the same draw, and the difference widens in marked thrombocytosis, which makes plasma the preferred specimen.6,8 Fragile leukemic cells can also release potassium after collection and elevate a plasma or serum result. In extreme leukocytosis, typically above 100 × 103/µL, metabolically active leukocytes can take potassium up from the plasma at room temperature and produce spurious hypokalemia. Prompt separation and rapid analysis limit both artifacts.
Fist clenching and prolonged tourniquet time release potassium from exercised forearm muscle during the draw. In unseparated specimens kept at room temperature, potassium often stays stable or falls slightly at first, because glycolysis still powers the sodium-potassium ATPase. Potassium rises once the cells deplete glucose and the pump fails.6,9 Cooling inhibits the pump and speeds the rise. Whole blood kept in slushed ice gained about 0.2 mmol/L of potassium per hour in one study, with most specimens between 0.13 and 0.28 mmol/L per hour.10 Keep routine potassium specimens at room temperature and separate them on schedule unless a validated protocol says otherwise. Iced specimens for combined blood-gas and electrolyte testing follow the acid-base lesson's handling rules. In vitro hemolysis is the most frequently flagged interference, and even mild hemolysis can raise potassium. The bias depends on the analyzer and method, so no fixed correction applies. Analyzers quantify a hemolysis index, and each laboratory pairs it with validated limits to suppress, qualify, repeat, or recollect. Potassium EDTA contamination, from additive carryover during collection or decanting between tube types, spuriously raises potassium and lowers calcium. Prevent additive transfer during collection. When contamination is suspected, review the collection history and obtain a suitable repeat specimen. When a potassium result is unexpected, review the hemolysis index, the blood count, the tube type, and the collection-to-analysis interval, and request a prompt recollection when the specimen is unsuitable. Follow your laboratory's urgent communication procedure during that investigation. Specimen checks must never delay notifying the clinical team of a valid critical result. Review the specimen promptly for every unexpected potassium result.3
Determination. Serum, heparinized plasma, and whole blood for direct-ISE analyzers are routine. A timed urine collection smooths dietary and diurnal variation. The steep erythrocyte-to-plasma gradient makes hemolysis and delayed separation the main specimen risks for potassium. The method is potentiometric ISE with valinomycin as the potassium-selective ionophore.1
Scroll sideways to see all columns
| Specimen | Reference interval |
|---|---|
| Serum | 3.5–5.1 mmol/L |
| Urine, 24 h | Diet-dependent; representative adult interval about 16 to 105 mmol/24 h |
Practice
References
- Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023. Back to text
- Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399-403. doi:10.1016/S0002-9343(99)00055-8 Back to text
- Centers for Medicare & Medicaid Services. 42 CFR §§493.1253 and 493.1291. Electronic Code of Federal Regulations. Accessed August 31, 2026. Back to text
- American Society for Clinical Pathology Board of Certification. MLS(ASCP) and MLS(ASCP)i Content Guideline. Revised June 9, 2026. Examination composite reference ranges, pp. 14-15. Back to text
- Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Adv Physiol Educ. 2016;40(4):480-490. doi:10.1152/advan.00121.2016 Back to text
- Delaney H. Potassium (serum, plasma, blood). Association for Clinical Biochemistry and Laboratory Medicine; 2013. Section 2: the 0.1 to 0.7 mmol/L serum-versus-plasma difference from platelet release during clotting, thrombocythemia, delayed separation, and cold storage. Accessed October 8, 2026. Back to text
- Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a KDIGO Controversies Conference. Kidney Int. 2020;97:42–61. Page 43 and Figure 1: ENaC-mediated voltage and apical potassium channels; acid-base status as a separate determinant. Accessed September 13, 2026. Back to text
- Graber M, Subramani K, Corish D, Schwab A. Thrombocytosis elevates serum potassium. Am J Kidney Dis. 1988;12(2):116-120. doi:10.1016/s0272-6386(88)80005-2 Back to text
- Boyanton BL Jr, Blick KE. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem. 2002;48(12):2242-2247. doi:10.1093/clinchem/48.12.2242 Back to text
- Zavorsky GS, van Wijk XMR, Gasparyan S, Stollenwerk NS, Brooks RA. Stability of whole blood electrolyte specimens at room temperature vs slushed ice conditions. J Appl Lab Med. 2022;7(2):541-554. doi:10.1093/jalm/jfab089 Back to text